These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27347907)

  • 1. Synthesis and Evaluation of Novel α-Aminoamides Containing an Indole Moiety for the Treatment of Neuropathic Pain.
    Li H; Fan S; Cheng J; Zhang P; Zhong B; Shi W
    Molecules; 2016 Jun; 21(7):. PubMed ID: 27347907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Evaluation of Novel α-Aminoamides Containing Benzoheterocyclic Moiety for the Treatment of Pain.
    Tong K; Zhang R; Ren F; Zhang T; He J; Cheng J; Yu Z; Ren F; Zhang Y; Shi W
    Molecules; 2021 Mar; 26(6):. PubMed ID: 33808667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery and biological evaluation of 5-aryl-2-furfuramides, potent and selective blockers of the Nav1.8 sodium channel with efficacy in models of neuropathic and inflammatory pain.
    Kort ME; Drizin I; Gregg RJ; Scanio MJ; Shi L; Gross MF; Atkinson RN; Johnson MS; Pacofsky GJ; Thomas JB; Carroll WA; Krambis MJ; Liu D; Shieh CC; Zhang X; Hernandez G; Mikusa JP; Zhong C; Joshi S; Honore P; Roeloffs R; Marsh KC; Murray BP; Liu J; Werness S; Faltynek CR; Krafte DS; Jarvis MF; Chapman ML; Marron BE
    J Med Chem; 2008 Feb; 51(3):407-16. PubMed ID: 18176998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailable pyrrolo-benzo-1,4-diazines as Na(v)1.7 sodium channel blockers for the treatment of pain.
    Yang SW; Ho GD; Tulshian D; Bercovici A; Tan Z; Hanisak J; Brumfield S; Matasi J; Sun X; Sakwa SA; Herr RJ; Zhou X; Bridal T; Urban M; Vivian J; Rindgen D; Sorota S
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4958-62. PubMed ID: 25288187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chimeric agents derived from the functionalized amino acid, lacosamide, and the α-aminoamide, safinamide: evaluation of their inhibitory actions on voltage-gated sodium channels, and antiseizure and antinociception activities and comparison with lacosamide and safinamide.
    Park KD; Yang XF; Dustrude ET; Wang Y; Ripsch MS; White FA; Khanna R; Kohn H
    ACS Chem Neurosci; 2015 Feb; 6(2):316-30. PubMed ID: 25418676
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain.
    Shao PP; Ok D; Fisher MH; Garcia ML; Kaczorowski GJ; Li C; Lyons KA; Martin WJ; Meinke PT; Priest BT; Smith MM; Wyvratt MJ; Ye F; Parsons WH
    Bioorg Med Chem Lett; 2005 Apr; 15(7):1901-7. PubMed ID: 15780630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of Indole- and Indazole-acylsulfonamides as Potent and Selective Na
    Luo G; Chen L; Easton A; Newton A; Bourin C; Shields E; Mosure K; Soars MG; Knox RJ; Matchett M; Pieschl RL; Post-Munson DJ; Wang S; Herrington J; Graef J; Newberry K; Sivarao DV; Senapati A; Bristow LJ; Meanwell NA; Thompson LA; Dzierba C
    J Med Chem; 2019 Jan; 62(2):831-856. PubMed ID: 30576602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and Opportunities for Therapeutics Targeting the Voltage-Gated Sodium Channel Isoform Na
    Mulcahy JV; Pajouhesh H; Beckley JT; Delwig A; Du Bois J; Hunter JC
    J Med Chem; 2019 Oct; 62(19):8695-8710. PubMed ID: 31012583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Voltage-gated Na+ channels in neuropathic pain.
    Hargus NJ; Patel MK
    Expert Opin Investig Drugs; 2007 May; 16(5):635-46. PubMed ID: 17461737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Future potential and status of selective sodium channel blockers for the treatment of pain.
    Priest BT
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):682-92. PubMed ID: 19736626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenoxyphenyl pyridines as novel state-dependent, high-potency sodium channel inhibitors.
    Shao B; Victory S; Ilyin VI; Goehring RR; Sun Q; Hogenkamp D; Hodges DD; Islam K; Sha D; Zhang C; Nguyen P; Robledo S; Sakellaropoulos G; Carter RB
    J Med Chem; 2004 Aug; 47(17):4277-85. PubMed ID: 15293999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computer-aided Discovery of a New Nav1.7 Inhibitor for Treatment of Pain and Itch.
    Chandra S; Wang Z; Tao X; Chen O; Luo X; Ji RR; Bortsov AV
    Anesthesiology; 2020 Sep; 133(3):611-627. PubMed ID: 32788559
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Zhang F; Zhang C; Xu X; Zhang Y; Gong X; Yang Z; Zhang H; Tang D; Liang S; Liu Z
    J Biol Chem; 2019 May; 294(18):7324-7334. PubMed ID: 30804211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of hermitamides A and B as human voltage-gated sodium channel blockers.
    De Oliveira EO; Graf KM; Patel MK; Baheti A; Kong HS; MacArthur LH; Dakshanamurthy S; Wang K; Brown ML; Paige M
    Bioorg Med Chem; 2011 Jul; 19(14):4322-9. PubMed ID: 21683602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of pyrrolo-benzo-1,4-diazines as potent Na(v)1.7 sodium channel blockers.
    Ho GD; Tulshian D; Bercovici A; Tan Z; Hanisak J; Brumfield S; Matasi J; Heap CR; Earley WG; Courneya B; Herr RJ; Zhou X; Bridal T; Rindgen D; Sorota S; Yang SW
    Bioorg Med Chem Lett; 2014 Sep; 24(17):4110-3. PubMed ID: 25113934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.
    Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI
    J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.
    Rapacz A; Kamiński K; Obniska J; Koczurkiewicz P; Pękala E; Filipek B
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):567-579. PubMed ID: 28188357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of aryl sulfonamide-selective Nav1.7 inhibitors with a highly hydrophobic ethanoanthracene core.
    Wang JT; Zheng YM; Chen YT; Gu M; Gao ZB; Nan FJ
    Acta Pharmacol Sin; 2020 Mar; 41(3):293-302. PubMed ID: 31316182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substituted Indazoles as Nav1.7 Blockers for the Treatment of Pain.
    Frost JM; DeGoey DA; Shi L; Gum RJ; Fricano MM; Lundgaard GL; El-Kouhen OF; Hsieh GC; Neelands T; Matulenko MA; Daanen JF; Pai M; Ghoreishi-Haack N; Zhan C; Zhang XF; Kort ME
    J Med Chem; 2016 Apr; 59(7):3373-91. PubMed ID: 27015369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The endocannabinoid anandamide inhibits voltage-gated sodium channels Nav1.2, Nav1.6, Nav1.7, and Nav1.8 in Xenopus oocytes.
    Okura D; Horishita T; Ueno S; Yanagihara N; Sudo Y; Uezono Y; Sata T
    Anesth Analg; 2014 Mar; 118(3):554-62. PubMed ID: 24557103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.